| # | Drug | Count |
|---|---|---|
| 0 | FLUOROURACIL | 10 |
| 1 | FLUOROURACIL CREAM, 0.5% | 10 |
| 2 | CARBOPLATIN | 9 |
| 3 | ETOPOSIDE | 9 |
| 4 | CISPLATIN | 8 |
| 5 | GEMCITABINE HYDROCHLORIDE | 8 |
| 6 | GEMCITABINE | 7 |
| 7 | OXALIPLATIN | 7 |
| 8 | DOXORUBICIN | 6 |
| 9 | VORINOSTAT | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VORINOSTAT | 6 | 0.0028 |
| 1 | VANDETANIB | 1 | 0.0006 |
| 2 | LUTETIUM LU 177 DOTATATE | 1 | 0.0002 |
| 3 | LEUCOVORIN CALCIUM | 3 | 0.0002 |
| 4 | GEMCITABINE HYDROCHLORIDE | 8 | 0.0001 |
| 5 | FLUOROURACIL CREAM, 0.5% | 10 | 0.0001 |
| 6 | FLUOROURACIL | 10 | 0.0001 |
| 7 | ETOPOSIDE | 9 | 0.0001 |
| 8 | TRANEXAMIC ACID | 1 | 0.0001 |
| 9 | CISPLATIN | 8 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Histone Deacetylase Inhibitor [EPC] | 6 | 0.0015 |
| 1 | Topoisomerase Inhibitor [EPC] | 9 | 0.0001 |
| 2 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 3 | Programmed Death Ligand-1 Blocker [EPC] | 2 | 0.0001 |
| 4 | Nonergot Dopamine Agonist [EPC] | 1 | 0.0001 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 12 | 0.0000 |
| 6 | Platinum-based Drug [EPC] | 11 | 0.0000 |
| 7 | Prostacyclin Receptor Agonist [EPC] | 1 | 0.0000 |
| 8 | Epidermal Growth Factor Receptor Antagonist [EPC] | 1 | 0.0000 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 2 | 0.0000 |